Science & Pipeline
PulmonarySotatercept | ||||
Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 | ApprovedApp | |
---|---|---|---|---|
Pulmonary Arterial Hypertension | ||||
Pulmonary Arterial Hypertension |
Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 | ApprovedApp | |
---|---|---|---|---|
ACE-1334 | ||||
SSc-ILD | ||||
SSc-ILD |
Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 | ApprovedApp | |
---|---|---|---|---|
HematologyREBLOZYL® | ||||
REBLOZYL® (luspatercept-aamt)Myelodysplastic Syndromes | ||||
Myelodysplastic | ||||
Beta-Thalassemia | ||||
Beta-Thalassemia |
luspatercept-aamt | ||||
Myelodysplastic Syndromes | ||||
Myelodysplastic | ||||
Beta-Thalassemianon-transfusion dependent | ||||
Beta-Thalassemianon-transfusion dependent | ||||
Myelofibrosis | ||||
Myelofibrosis |
* Bristol Myers Squibb-sponsored